A simple assay for determination of iron release from ferritin in neuroblastoma cells.
A commercially available enzyme immunoassay was used to determine ferritin content and subsequently the loading and release of iron from ferritin in neuroblastoma cells. LS cells were incubated with 59Fe for 24 h, lysed, and the cytoplasmic ferritin was bound to monoclonal antibodies coupled to globules. After determination of the ferritin content the same globules with bound radioactive ferritin were measured in a gamma-counter. To illustrate the applicability of this test system, increased iron loading of cellular ferritin could be demonstrated in cycloheximide-treated cells; furthermore, release of iron was documented after incubation of LS cells with a combination of 6-hydroxydopamine and ascorbate. The assay turned out to be a simple method for determination of changes in 59Fe content of ferritin in neuroblastoma cells.
Baader
S L
SL
Children's Hospital, Dept. Hematology and Oncology, University of Tübingen, Germany.
Bruchelt
G
G
Handgretinger
R
R
Niethammer
D
D
D001205:Ascorbic Acid; D003513:Cycloheximide / Q000494:pharmacology; D005293:Ferritins / Q000378:metabolism*; D005296:Ferrous Compounds / Q000494:pharmacology; D006801:Humans; D007124:Immunoenzyme Techniques; D007501:Iron / Q000378:metabolism*; D007504:Iron Radioisotopes; D009447:Neuroblastoma / Q000378:metabolism* / Q000473:pathology; D016627:Oxidopamine; D014407:Tumor Cells, Cultured
D005296:Ferrous Compounds; D007504:Iron Radioisotopes; C020748:ferrous sulfate; D016627:Oxidopamine; D005293:Ferritins; D003513:Cycloheximide; D007501:Iron; D001205:Ascorbic Acid